Loading viewer...
investor_presentation
Format: PDF investor_presentation
Genmab's Q1 2024 results presentation highlights strategic partnerships, collaborations, and licensing agreements impacting future operations.
investor_presentation
Concord Biotech Investor Presentation 2023
investor_presentationinvestor_presentation
37 Pages
Concord Biotech Limited
Tonix Tonmya TNX-102 SL Fibromyalgia 2024
investor_presentationinvestor_presentation
22 Pages
Tonix Pharmaceuticals Holding Corp.